Enedra Therapeutics Limited
13433538
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/07/2025
total exemption full
Next accounts due
30/04/2027
Confirmation statement
Last: 01/06/2025
Due 15/06/2026
Industry
Officers
director · Since 15/10/2021
SENIOR BUSINESS DEVELOPMENT EXECUTIVE
BRITISH · UNITED KINGDOM · Age 51
Also on 1 other board
director · Since 11/04/2023
CONSULTANT
BRITISH · ENGLAND · Age 66
Also on 1 other board
director · Since 06/11/2024
MANAGING DIRECTOR
BELGIAN · BELGIUM · Age 51
director · Since 04/09/2025
BIOPHARMA EXECUTIVE
BRITISH · ENGLAND · Age 55
Also on 1 other board
Persons with Significant Control
Mr Andreas Ballis
Greek · United Kingdom · Age 47
Salisbury House, Station Road, Cambridge, CB1 2LA
Notified 02/06/2021
Former PSCs
Alexander Paul Gutteridge
Ceased 04/03/2022
CompanyRankvs 826+ SIC 72190 peers77
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/07/2025
Net Worth
£388k
Balance sheet strength
Cash
£37k
Cash in the bank
Net Current Assets
£388k
Working capital
Current Assets
£408k
Current Liabilities
£20k
Fixed Assets
£638
Debtors
£371k
People Costs(2024)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 20.23 | +£334k |
| 2024 | 1.08 | +£149k |
| 2023 | 0.51 | -£70k |
| 2022 | 2.15 | — |
Derived from filed accounts. Not audited figures.